Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Top Cited Papers
- 21 December 2014
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 385 (9976), 1418-1427
- https://doi.org/10.1016/s0140-6736(14)61469-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphomaPublished by Wiley ,2010
- Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's DiseaseNew England Journal of Medicine, 2007
- FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease-a useful tool for monitoring pulmonary toxicity and disease activityHaematologica, 2007
- Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 TrialJournal of Clinical Oncology, 2007
- Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsAnnals of Oncology, 2006
- Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- How Important Is Bleomycin in the Adriamycin + Bleomycin + Vinblastine + Dacarbazine Regimen?Journal of Clinical Oncology, 2004
- Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trialBlood, 2004
- Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical TrialJournal of Clinical Oncology, 2002
- Results of a randomized study of early stage Hodgkin's disease using ABVD, EBVD, or MBVDMedical and Pediatric Oncology, 1995